MRVI Maravai LifeSciences Holdings, Inc.
MRVI Maravai LifeSciences Holdings, Inc.
Healthcare · Biotechnology
Market read
POC $3.55 · VWAP $5.36 · +26.8% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
MRVI Price Structure
Loading timeframes…
Peers
Every watchlist MRVI belongs to, members best 30-day change first — MRVI highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Against street estimates
How MRVI's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
Recent news
Headlines about MRVI from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 14 days ago · Oct 3
- Maravai LifeSciences Holdings Inc (MRVI) (Q2 2026) Earnings Call
- Maravai LifeSciences Holdings, Inc. (MRVI)
- Maravai Lifesciences Holdings Stock Price Forecast. Should You Buy MRVI?
- Maravai Lifesciences Holdings, Inc. (MRVI) 10-Q Quarterly Report August 2026
- Maravai Lifesciences Holdings Inc Stock Price Today | NASDAQ: MRVI Live - Investing.com
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
MRVI research tape
8 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.